Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of isavuconazole against deep-seated mycoses: A phase 3, randomized, open-label study in Japan.
Kohno S, Izumikawa K, Takazono T, Miyazaki T, Yoshida M, Kamei K, Ogawa K, Taniguchi S, Akashi K, Tateda K, Mukae H, Miyazaki Y, Okada F, Kanda Y, Kakeya H, Suzuki J, Kimura SI, Kishida M, Matsuda M, Niki Y. Kohno S, et al. Among authors: miyazaki t, miyazaki y. J Infect Chemother. 2023 Feb;29(2):163-170. doi: 10.1016/j.jiac.2022.10.010. Epub 2022 Oct 25. J Infect Chemother. 2023. PMID: 36307059 Free article. Clinical Trial.
Echinocandin Resistance in Candida auris Occurs in the Murine Gastrointestinal Tract Due to FKS1 Mutations.
Hirayama T, Miyazaki T, Sumiyoshi M, Ito Y, Ashizawa N, Takeda K, Iwanaga N, Takazono T, Yamamoto K, Izumikawa K, Yanagihara K, Makimura K, Tsukamoto K, Kohno S, Mukae H. Hirayama T, et al. Among authors: miyazaki t. Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0124322. doi: 10.1128/aac.01243-22. Epub 2023 Mar 15. Antimicrob Agents Chemother. 2023. PMID: 36920237 Free PMC article.
Evaluation of a Novel FKS1 R1354H Mutation Associated with Caspofungin Resistance in Candida auris Using the CRISPR-Cas9 System.
Kiyohara M, Miyazaki T, Okamoto M, Hirayama T, Makimura K, Chibana H, Nakada N, Ito Y, Sumiyoshi M, Ashizawa N, Takeda K, Iwanaga N, Takazono T, Izumikawa K, Yanagihara K, Kohno S, Mukae H. Kiyohara M, et al. Among authors: miyazaki t. J Fungi (Basel). 2023 Apr 29;9(5):529. doi: 10.3390/jof9050529. J Fungi (Basel). 2023. PMID: 37233240 Free PMC article.
Safety and efficacy of 5-aminolevulinic acid phosphate/iron in mild-to-moderate coronavirus disease 2019: A randomized exploratory phase II trial.
Tanaka T, Tashiro M, Ota K, Fujita A, Sawai T, Kadota J, Fukuda Y, Sumiyoshi M, Ide S, Tachikawa N, Fujii H, Hibino M, Shiomi H, Izumida M, Matsui K, Yamauchi M, Takahashi K, Yamanashi H, Sugimoto T, Akabame S, Umeda M, Shimizu M, Hosogaya N, Kosai K, Takeda K, Iwanaga N, Ashizawa N, Hirayama T, Takazono T, Yamamoto K, Imamura Y, Miyazaki T, Kobayashi Y, Ariyoshi K, Mukae H, Yanagihara K, Kita K, Izumikawa K. Tanaka T, et al. Among authors: miyazaki t. Medicine (Baltimore). 2023 Aug 25;102(34):e34858. doi: 10.1097/MD.0000000000034858. Medicine (Baltimore). 2023. PMID: 37653769 Free PMC article. Clinical Trial.
A high α1-antitrypsin/interleukin-10 ratio predicts bacterial pneumonia in adults with community-acquired pneumonia: a prospective cohort study.
Miyazaki T, Fukushima K, Hashiguchi K, Ide S, Kobayashi T, Sawai T, Yatera K, Kohno Y, Fukuda Y, Futsuki Y, Matsubara Y, Koga H, Mihara T, Sasaki E, Ashizawa N, Hirayama T, Takazono T, Yamamoto K, Imamura Y, Kaku N, Kosai K, Morinaga Y, Yanagihara K, Mukae H. Miyazaki T, et al. Pneumonia (Nathan). 2023 Oct 25;15(1):16. doi: 10.1186/s41479-023-00118-4. Pneumonia (Nathan). 2023. PMID: 37876022 Free PMC article.
Development of a score model to predict long-term prognosis after community-onset pneumonia in older patients.
Takazono T, Namie H, Nagayoshi Y, Imamura Y, Ito Y, Sumiyoshi M, Ashizawa N, Yoshida M, Takeda K, Iwanaga N, Ide S, Harada Y, Hosogaya N, Takemoto S, Fukuda Y, Yamamoto K, Miyazaki T, Sakamoto N, Obase Y, Sawai T, Higashiyama Y, Hashiguchi K, Funakoshi S, Suyama N, Tanaka H, Yanagihara K, Izumikawa K, Mukae H. Takazono T, et al. Among authors: miyazaki t. Respirology. 2024 Aug;29(8):722-730. doi: 10.1111/resp.14752. Epub 2024 May 20. Respirology. 2024. PMID: 38769707
TAC1b mutation in Candida auris decreases manogepix susceptibility owing to increased CDR1 expression.
Hirayama T, Miyazaki T, Tanaka R, Kitahori N, Yoshida M, Takeda K, Ide S, Iwanaga N, Tashiro M, Takazono T, Izumikawa K, Yanagihara K, Makimura K, Tsukamoto K, Mukae H. Hirayama T, et al. Among authors: miyazaki t. Antimicrob Agents Chemother. 2024 Dec 18:e0150824. doi: 10.1128/aac.01508-24. Online ahead of print. Antimicrob Agents Chemother. 2024. PMID: 39692503 Free article.
Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae isolates cultured from Japanese adult patients with community-acquired pneumonia in Goto City, Japan.
Miyazaki T, van der Linden M, Hirano K, Maeda T, Kohno S, Gonzalez EN, Zhang P, Isturiz RE, Gray SL, Grant LR, Pride MW, Gessner BD, Jodar L, Arguedas AG. Miyazaki T, et al. Front Microbiol. 2024 Sep 24;15:1458307. doi: 10.3389/fmicb.2024.1458307. eCollection 2024. Front Microbiol. 2024. PMID: 39380682 Free PMC article.
Resolvin D4 mitigates lipopolysaccharide-induced lung injury in mice.
Inomata R, Tsubouchi H, Takao T, Kurokawa M, Yanagi S, Sakai K, Miyazaki T. Inomata R, et al. Among authors: miyazaki t. Prostaglandins Leukot Essent Fatty Acids. 2024 Apr;203:102652. doi: 10.1016/j.plefa.2024.102652. Epub 2024 Sep 28. Prostaglandins Leukot Essent Fatty Acids. 2024. PMID: 39368237 Free article.
4,306 results